D. E. Shaw & Co., Inc. Galera Therapeutics, Inc. Transaction History
D. E. Shaw & Co., Inc.
- $114 Billion
- Q1 2024
Shares
2 transactions
Others Institutions Holding GRTX
# of Institutions
38Shares Held
10.7MCall Options Held
10.3KPut Options Held
0-
Gsa Capital Partners LLP London, X03.63MShares$508,5670.04% of portfolio
-
Blackstone Inc New York, NY1.68MShares$235,0570.0% of portfolio
-
Abrdn PLC898KShares$125,7720.0% of portfolio
-
Tekla Capital Management LLC898KShares$125,7720.11% of portfolio
-
Nan Fung Group Holdings LTD Central, K3613KShares$85,8510.08% of portfolio
About Galera Therapeutics, Inc.
- Ticker GRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,821,600
- Market Cap $3.76M
- Description
- Galera Therapeutics, Inc., a clinical stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for the transformation of radiotherapy in cancer. The company's lead product candidate is avasopasem manganese (GC4419), a small molecule superoxide dismutase mimetic, which has completed Phase III clinical tria...